ivWatch Seeks 510(k) Clearance for its SmartTouch+ Sensor to Expand Continuous IV Monitoring to White-Opaque Infusates

Shots:

• The US FDA has received a 510(k) application for the SmartTouch+ Sensor to detect infiltration & extravasation events associated with both clear and white-opaque fluids early
• The SmartTouch+ Sensor expands ivWatch’s monitoring to lipid-based fluids like TPN & propofol, with the Patient Monitor performing 18,000+ checks/hour to detect infiltration or extravasation & alert clinicians, often hours before visual or tactile signs appear
• SmartTouch+ is patent pending & under the US FDA review following submission of a 510(k) application, expanding ivWatch’s monitoring capabilities for lipid-based fluids

Ref: PRnewswire   |   Image: ivWatch   |   Press Release

PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com